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and is strongly potentiated by IL-4 and the IL-4-induced
transcription factor STAT6 (reviewed in Abbas et al.,
1996; O'Garra, 1998). In contrast, the second step of
acute IL-4 gene transcription is much less dependent
on STAT6 and IL-4 (Lederer et al., 1996; Huang et al.,
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1997). The early stages of Th2 differentiation are accom-Boston, Massachusetts 02115
panied by long-range changes in the DNase I hypersen-
sitivity pattern and DNA methylation status of the IL-4/
IL-5/ IL-13 gene cluster (Agarwal and Rao, 1998; BirdSummary
et al., 1998; Takemoto et al., 1998). They are also marked
by selective up- or downregulation of transcription fac-By DNase I hypersensitivity analysis, we have identi-
tors and cell surface receptors characteristic of the Th2fied an inducible, cyclosporin A±sensitive enhancer
lineage (Ho et al., 1996; Szabo et al., 1997a; Zheng andlocated 39 of the interleukin-4 (IL-4) gene. The en-
Flavell, 1997; Sallusto et al., 1998).hancer binds the Th2-specific transcription factor
The antigen-induced transcription factor NFAT andGATA3 in vivo but is not perceptibly influenced by the
its cooperating transcription factor AP-1 (Fos/Jun) areabsence of a second Th2-specific factor, cMaf. The
implicated in the second phase of induced IL-4 geneantigen-inducible transcription factor NFAT1 binds the
transcription by differentiated Th2 cells (reviewed in RaoIL-4 enhancer and the IL-4 promoter only in stimulated
et al., 1997). NFAT is a family of proteins that includesTh2 cells; conversely, NFAT1 binds to the interferon
the four calcium-regulated transcription factors NFAT1(IFN)-g promoter only in stimulated Th1 cells. Our re-
(NFATp, NFATc2), NFAT2 (NFATc, NFATc1), NFAT3sults support a model whereby transcription factors
(NFATc4), and NFAT4 (NFATc3) (reviewed in Rao et al.,such as NFAT1, which are nonselectively induced in
1997; Crabtree, 1999; Kiani et al., 2000); a fifth NFATantigen-stimulated T cells, gain access to cytokine
protein, NFAT5/ TonEBP, is regulated by osmotic shockregulatory regions only in the appropriate subset of
(Lopez-Rodriguez et al., 1999; Miyakawa et al., 1999).differentiated T cells in vivo. This restricted access
Activation of the four calcium-regulated NFAT proteinsenables antigen-dependent and subset-specific tran-
(hereafter abbreviated NFAT) requires the calcium/cal-scription of cytokine genes.
modulin-dependent phosphatase calcineurin and is in-
hibited by the immunosuppressive agents cyclosporin AIntroduction
(CsA) and FK506. In transgenic mice, reporter activity
driven by multiple copies of a composite NFAT-AP-1The immunomodulatory cytokine interleukin-4 (IL-4)
site was higher in Th2 than in Th1 cells (Rincon andplays a central role in the development of effector B and
Flavell, 1997b; Wenner et al., 1997), possibly because
T cells and is critical for host defense during parasitic
Th2 cells express several-fold higher levels of the AP-1
infections. Dysregulation of IL-4 expression results in
family member JunB (Li et al., 1999). It is generally as-
uncontrolled allergic inflammation and aberrant immune sumed, however, that because NFAT itself is nonselec-
responses to pathogens (reviewed in Abbas et al., 1996; tively induced in both Th1 and Th2 cells (reviewed in
O'Garra, 1998). IL-4 expression is, in general, mutually Szabo et al., 1997b; Kuo and Leiden, 1999), it cannot
exclusive with the expression of interferon (IFN)-g, a explain the subset specificity of cytokine gene expres-
cytokine with a major influence on the inflammatory re- sion. Rather, transcription factors that are selectively
sponse. T helper (Th) cells that produce the inflamma- expressed in Th1 or Th2 lineage cells are likely to be
tory cytokines IFN-g and TNF but not IL-4 are classified involved.
in the Th1 subset, while Th cells that produce IL-4 but The transcription factors cMaf (Maf) and GATA3 show
not IFN-g are classified in the Th2 subset (reviewed in a striking level of Th2 restriction. Both Maf and GATA3
Abbas et al., 1996; Mosmann and Sad, 1996; O'Garra, are expressed at low levels in naive T cells and become
1998). In addition, Th2 cells show coordinate expression upregulated during Th2 differentiation; both are consti-
of the closely linked IL-5 and IL-13 genes. tutively expressed in differentiated Th2 cells but not in
Transcription of the IL-4 gene by T cells is regulated differentiated Th1 cells; and both are targets of the IL-
in two distinct steps (reviewed in Rincon and Flavell, 4-dependent transcription factor STAT6 (Ho et al., 1996;
1997a; Szabo et al., 1997b; Agarwal and Rao, 1998; Zhang et al., 1997; Zheng and Flavell, 1997; Kurata et
Murphy, 1998; O'Garra, 1998; Agarwal et al., 1999). The al., 1999). Analysis of Maf-deficient and Maf-transgenic
first step involves the differentiation of naive T cells into mice indicates that Maf exerts a selective effect on IL-4
mature effector Th2 cells, while the second step is the gene expression without directly affecting the expres-
inducible transcription of the IL-4 gene by the differenti- sion of other Th2 cytokines including IL-5, IL-6, IL-10,
ated Th2 cells. Th2 differentiation is triggered when na- and IL-13 (Ho et al., 1998; Kim et al., 1999). In contrast,
ive T cells initially encounter antigen in the periphery GATA3 appears to have a global effect on Th2 differenti-
ation. Differentiated Th1 cells from GATA3-transgenic
mice showed increased expression of mRNAs encoding* To whom correspondence should be addressed (e-mail: arao@
IL-4, IL-6, and IL-10 (Zheng and Flavell, 1997); GATA3-cbr.med.harvard.edu).
² These authors contributed equally to this paper. overexpressing B and primary Th1 cell lines showed
Immunity
644
Figure 1. TCR or Ionomycin Stimulation of Primary Th2 Cells Induces a Novel DNase I HS Site Located 39 of the IL-4 Gene
(A) Stimulation with anti-CD3. Primary Th2 cells differentiated for 2 weeks were either left unstimulated (panel 1) or stimulated for 6 hr using
plate-bound anti-CD3e (panel 2). Cells were subjected to DNase I HS analysis and membranes were hybridized using a probe from the 39 end
of the 19 kb BamHI fragment spanning the IL-4 gene (Agarwal and Rao, 1998). The constitutive HS sites IV and V (Agarwal and Rao, 1998)
and the inducible site VA are indicated. The use of a 59 promoter probe did not reveal any other inducible sites.
(B) Requirement for calcium and calcineurin. DNase I HS analysis of primary Th2 cells differentiated for 1 week and then either left unstimulated
(panel 1) or stimulated for 6 hr with PMA and ionomycin (P 1 I, panel 2), ionomycin alone (panel 3), or PMA, ionomycin, and CsA (P 1 I 1
CsA, panel 4). Membranes were hybridized using the 39 probe described in (A). The inducible site VA is indicated by an asterisk in panels 2
and 3.
(C) Map of the murine IL-4 locus showing the approximate location of the constitutive DNase I HS sites and the location of the inducible HS
site VA. The 39 probe used in (A) and (B) is indicated. The expanded view shows the 1.2 kb HindIII±SwaI fragment containing the inducible
site VA, with the restriction sites used in Figure 3A indicated.
striking induction of IL-5 (Ranganath et al., 1998; Zhang impressive than that of the endogenous IL-4 gene. These
results point to the existence of distal enhancer ele-et al., 1998); expression of antisense GATA3 in a differen-
tiated Th2 clone led to decreased expression of IL-4, ments that cooperate with the IL-4 promoter to modulate
IL-4 gene expression in vivo.IL-5, IL-6, and IL-10 (Zheng and Flavell, 1997); expres-
sion of dominant-negative GATA3 in transgenic mice Here we have used DNase I hypersensitivity mapping
and transient transfection assays to identify a distal IL-4led to reduced expression of IL-4, IL-5, and IL-13 (Zhang
et al., 1999); and expression of GATA3, even in STAT6- enhancer located 39 of the IL-4 gene. The enhancer was
discovered as an inducible DNase I hypersensitive (HS)deficient T cells, resulted in production of Th2 cytokines
and appearance of the differentiated Th2 pattern of site appearing in stimulated Th2 cells but not in either
resting or stimulated Th1 cells. T cells lacking Maf con-DNase I hypersensitivity on the IL-4 locus (Ouyang et
al., 2000). tinued to show appearance of both the constitutive and
the inducible pattern of DNase I HS sites, suggestingThe regulation of IL-4 gene transcription has been
studied by many laboratories. With a few exceptions that Maf is not critical for chromatin remodeling of the
IL-4 gene by naive T cells or for the activity of the IL-4(Henkel et al., 1992; Kubo et al., 1997; Agarwal and Rao,
1998; Bird et al., 1998; Takemoto et al., 1998), essentially enhancer. In contrast, chromatin immunoprecipitation
assays showed that the enhancer binds GATA3 in differ-all the focus has been on the proximal IL-4 promoter
(reviewed in Brown and Hural, 1997; Rincon and Flavell, entiated Th2 cells in vivo, consistent with the possibility
that GATA3 is required for enhancer function. Both the1997a; Szabo et al., 1997b; Murphy, 1998). Transgenic
experiments have documented, however, that the IL-4 IL-4 enhancer and the IL-4 promoter bind the NFAT
family member NFAT1 only in stimulated Th2 cells; con-promoter does not suffice for optimal IL-4 gene tran-
scription in vivo (Wenner et al., 1997). The levels of induc- versely, the IFN-g promoter binds NFAT1 only in stimu-
lated Th1 cells. These results define an antigen-respon-ible transcription from an IL-4 promoter-reporter trans-
gene were several orders of magnitude lower than those sive, NFAT-dependent, GATA3 binding distal regulatory
element in the IL-4 gene, and suggest a mechanism byobserved for the endogenous IL-4 gene. Furthermore,
although the integrated promoter-reporter construct which nonselectively induced transcription factors such
as NFAT may regulate subset-specific transcription ofachieved a considerable degree of Th2 specificity (z40-
fold), the level of differential expression was much less cytokine genes.
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Figure 2. Only Remodeled Cytokine Loci Re-
spond to Acute Stimulation with Further
Changes in Chromatin Structure
(A) DNase I HS analysis of the IL-4 locus in
D10 (Th2) and D5 (Th1) cells either left unstim-
ulated (panels 1 and 3) or stimulated for 6 hr
with PMA and ionomycin (P 1 I, panels 2 and
4). Membranes were hybridized using the 39
probe indicated in Figure 1. Constitutive HS
sites are indicated, and the inducible HS site
VA is marked with an asterisk.
(B) DNase I HS analysis of the IFN-g locus in
unstimulated and stimulated (P 1 I) D10 and
D5 cells. Blots from (A) were stripped and
rehybridized using an IFN-g exon 4 probe.
Th1-specific constitutive HS sites (Agarwal
and Rao, 1998) are indicated in panel 3.
Results of the D5 (Ar-5) Th1 clone did not result in induction of
site VA, nor did it cause any other change in DNase I
HS patterns throughout the IL-4 locus (Figure 2A, panelsIdentification of Inducible Hypersensitive Site
VA in the IL-4 Gene 3 and 4). However, D5 cells displayed clear changes in
the chromatin structure of the IFN-g locus following PMATo identify promoter-distal regulatory elements associ-
ated with stimulated transcription of the IL-4 gene, we plus ionomycin stimulation, with the most prominent
effect being disappearance of HS site II (Figure 2B, pan-compared DNase I hypersensitivity patterns on the IL-4
locus of unstimulated and stimulated Th2 cells (Figure els 3 and 4). No marked changes were observed in the
DNase I HS pattern of the IFN-g locus in stimulated D101). CD4 T cells, differentiated under polarizing Th2 condi-
tions for 1 week, showed the expected constitutive pat- cells (Figure 2B, panels 1 and 2). Therefore, despite
identical stimulation of the D5 Th1 and D10 Th2 celltern of DNase I hypersensitivity (Agarwal and Rao, 1998)
(Figure 1A, left panel). These resting cells did not pro- clones, the changes in chromatin structure that corre-
lated with active transcription were restricted to thoseduce detectable levels of IL-4 transcripts. In contrast,
cells stimulated with plate-bound anti-CD3 produced cytokine loci that had undergone stable chromatin re-
modeling during T cell differentiation.abundant levels of IL-4 mRNA and exhibited a novel,
inducible HS site (Figure 1A, right panel). We termed this The transcription factor Maf, which is expressed at
elevated levels in Th2 cells relative to Th1 cells, hasinducible HS site ªVAº (ªfive Aº) based on its proximity to
the Th2-specific constitutive HS site V (ªfiveº) and its been implicated in IL-4 gene transcription (Ho et al.,
1996, 1998; Kim et al., 1999). To determine whether Mafdependence on activation. Site VA was also observed
in primary Th2 cells and Th2 clones stimulated either contributes to the changes in chromatin structure on
with phorbol ester (PMA) plus calcium ionophore (iono- the IL-4 locus, either during Th2 differentiation or during
mycin) or with ionomycin alone (Figure 1B, panels 2 and acute stimulation of differentiated Th2 cells, we incu-
3), and its appearance was abrogated by the immuno- bated CD4 T cells from normal and Maf-deficient mice
suppressive agent cyclosporin A (CsA) (Figure 1B, panel with IL-4 and anti-IL-12 (Th2 differentiation conditions).
4). Site VA mapped z12 kb 39 of the IL-4 promoter and Following this period of differentiation, we compared
5 kb 39 of the end of the IL-4 coding region (Figure 1C). DNase I HS patterns in resting and PMA plus ionomycin
stimulated cells (Figure 3). DNase I hypersensitivity map-
ping with a 59 probe encompassing the IL-4 promoterAppearance of Inducible HS Site VA Is Th2 Restricted
revealed no differences in the resting DNase I HS patternbut Does Not Require the Transcription Factor cMaf
of normal versus Maf-deficient T cells (Figure 3A), indi-The formation of site VA was strictly Th2 restricted in
cating that Maf is not required for the long-rangevivo (Figure 2). Stimulation of the D10 Th2 clone with
changes in chromatin structure that occur in the IL-4PMA plus ionomycin resulted in strong induction of site
VA (Figure 2A, panels 1 and 2). In contrast, stimulation genetic locus during Th2 differentiation. Likewise, the
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Figure 3. The Th2-Restricted Transcription Factor Maf Is Not Required for Formation of Constitutive or Inducible DNase I HS Sites in the IL-4
Locus
CD4 T cells were purified from the lymph nodes and spleens of wild-type or Maf-deficient mice and differentiated under strongly polarizing
Th2 conditions for one week.
(A) DNase I HS analysis was performed on resting cultures of wild-type and Maf2/2 Th2 cells. Genomic DNA was digested to completion with
BamHI and subjected to Southern analysis using a probe corresponding to the 59 end of the IL-4 locus.
(B) Wild-type and Maf2/2 Th2 cells were either left unstimulated (panels 1 and 2) or stimulated for 6 hr with 20 nM PMA and 2 mM ionomycin
(panels 3 and 4). Cells were harvested and subjected to DNase I HS analysis. Membranes were hybridized using a probe corresponding to
the 39 end of the IL-4 locus (as in Figure 1).
use of a probe from the 39 end of the IL-4 locus revealed driven by a minimal SV40 promoter (Figure 5A; pGL3-
VA 438). A shorter (300 bp) PstI±SwaI fragment retainedno differences in DNase I HS patterns in either resting
or stimulated cells (Figure 3B), indicating that Maf also essentially all the enhancer activity of the 438 bp frag-
ment (Figure 5A; pGL3-VA 300). When tested with thedoes not play a role in the stimulation-dependent ap-
pearance of the inducible HS site VA. These results are IL-4 promoter, the fragment conferred 60-fold enhance-
ment of induced transcription in stimulated D10 cellsconsistent with the finding that Maf regulates expression
of only the IL-4 gene in the IL-4/IL-5/IL-13 gene cluster compared to 30-fold enhancement with the IL-4 pro-
moter alone (Figure 5B). The lower effect of the enhancerby virtue of its ability to bind a site in the IL-4 promoter
(Ho et al., 1996, 1998; Kim et al., 1999). in combination with the IL-4 promoter reflects the fact
that the IL-4 promoter itself is highly active in stimulated
cells. The enhancer conferred no increase in basal tran-Hypersensitive Site VA Exhibits Inducible,
CsA-Sensitive Enhancer Activity scription from either the SV40 promoter or the IL-4 pro-
moter in unstimulated D10 T cells, indicating that stimu-in Th2 Cells
To determine whether the inducible HS site VA plays a lation was absolutely required for enhancer activity
(Figures 5A and 5B).functional role in IL-4 gene transcription, we localized
it to a short restriction fragment and tested its function
in transient transfection assays (Figure 4). First, we used Subset-Restricted Binding of NFAT to Cytokine
Regulatory Regions In VivoHS analysis to map site VA to a 438 bp EcoRI±SwaI
fragment, hereafter termed the core IL-4 enhancer (Fig- The requirements for appearance of site VA (Figure 1)
and the properties of the site VA enhancer (Figure 5)ure 4A). The restriction map of this region is shown in
Figure 1C and its sequence in Figure 4B. Restriction paralleled the requirements for nuclear translocation
and activation of NFAT (Rao et al., 1997). Inspectionenzyme accessibility experiments confirmed that the
SwaI site was localized to the vicinity of the inducible of the nucleotide sequence of the enhancer fragment
(Figure 4B) revealed four potential NFAT binding siteshypersensitive site (Figure 4C). When SwaI was diffused
into intact nuclei, its ability to cleave the IL-4 locus in- (T/AGGAA; Rao et al., 1997), which bound NFAT when
tested in electrophoretic mobility shift assays (EMSA)creased after stimulation of D10 but not D5 cells (Figure
4C, compare lanes 2 and 4 with 6 and 8), indicating that in vitro. Binding was nonselective, since it was observed
with nuclear extracts from stimulated D5 as well as D10the ªaccessibilityº of this genomic region to both DNase
I and SwaI increased in a Th2-specific manner upon T cells (data not shown). These results confirm previous
work demonstrating equivalent induction of NFAT in nu-stimulation.
DNA fragments containing HS site VA behaved as in- clear extracts from stimulated Th1 and Th2 cells (Rooney
et al., 1994; Li-Weber et al., 1997; Rincon and Flavell,ducible, CsA-sensitive enhancer elements in transient
transfection assays in D10 cells (Figure 5). A single copy 1997b).
To reconcile the nonselective binding of NFAT to siteof a 438 bp EcoRI±SwaI fragment spanning the core
enhancer conferred both PMA/ionomycin responsive- VA in vitro with the Th2-specific appearance of site VA in
vivo (Figure 2), we used chromatin immunoprecipitationness and CsA sensitivity on a luciferase reporter plasmid
Binding of NFAT to a Novel IL-4 Enhancer In Vivo
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Figure 4. Localization and Sequence of Inducible HS Site VA
(A) Mapping of DNase I HS site VA to a 438 bp fragment EcoRI±SwaI fragment 39 of the IL-4 gene. Lanes 1±5, D10 nuclei were subjected to
DNase I titration, and the genomic DNA was digested to completion with HindIII and analyzed on a Southern blot. Lanes 6±10, markers were
provided by D10 genomic DNA digested to completion with Hind III and the indicated restriction enzymes. Membranes were hybridized with
a probe derived from the 59 end of a 5.5 kb HindIII fragment containing both sites V and VA (see Figure 1C). The top half of this autoradiogram
and the lanes containing the markers were exposed for a shorter time than the bottom half, necessitated by the fact that the intensity of the
parent band and of the markers was much greater than that of the hypersensitive band.
(B) Restriction enzyme accessibility analysis of the SwaI site in resting and stimulated D5 and D10 cells. Cells were left unstimulated (2) or
were stimulated (1) for 6 hr with PMA and ionomycin (P 1 I). Nuclei were prepared and left untreated (2) or treated (1) for 1 hr with SwaI,
following which DNA was purified and digested to completion with HindIII. Southern blots were hybridized as described in (A). The relative
intensities of the 1.2 kb band in lanes 2, 4, 6, and 8 (expressed as a percentage of the total intensity in the lane) were 2.5%, 3.0%, 7.7%, and
40.6%, respectively.
(C) Nucleotide sequence of the 438 bp EcoRI±SwaI fragment encompassing the IL-4 enhancer. Relevant restriction enzyme sites are underlined
and labeled. Sequences that match consensus binding motifs (on either DNA strand) for NFAT (A/TGGAA) (Rao et al., 1997), GATA (A/TGATAA/G)
(Ko and Engel, 1993), and STAT [TTC(X)3±4GAA] (Schindler et al., 1995) transcription factors are shown in bold.
(ChIP) assays (Figure 6). The ChIP technique can estab- (ªchromatinº) were immunoprecipitated from stimulated
D10 (Th2) but not D5 (Th1) cells (Figure 6A, comparelish whether a known transcription factor truly binds in
the vicinity of a known regulatory element in living cells lanes 3 and 4). Conversely, NFAT1 bound to the endoge-
nous IFN-g promoter, which contains a putative NFAT(Parekh and Maniatis, 1999). Three of the four calcium-
regulated NFAT proteins, NFAT1, NFAT2 and NFAT4, site (Rao et al., 1997), only in stimulated D5 cells (Figure
6B, compare lanes 3 and 4). Control experimentsare expressed in T cells (Timmerman et al., 1996; Lyakh
et al., 1997); of these, we chose to examine NFAT1 since showed that the IL-4 promoter and enhancer sequences
were present at equivalent concentrations in templateit is the most abundant NFAT protein in T cells, constitut-
ing 80%±90% of total NFAT (Xanthoudakis et al., 1996). DNA from D5 and D10 cells (Figure 6C). ChIP analysis
using primary differentiated Th1 and Th2 cells confirmedMoreover, NFAT1 can potently transactivate the IL-4
promoter, especially in combination with Maf (Ho et al., that NFAT1 binding to the IL-4 enhancer was dependent
on stimulation, as expected from the fact that NFAT1 is1996; Hodge et al., 1996a). ChIP assays using anti-
NFAT1 antibodies showed that NFAT1 bound to both nuclear only in stimulated cells (Rao et al., 1997) (Figure
6D). We conclude that the IL-4 promoter and enhancerthe IL-4 promoter and IL-4 enhancer regions in an induc-
ible and Th2-specific manner in vivo: that is, PCR prod- are selectively accessible to NFAT1 binding in Th2 cells,
while the IFN-g promoter is selectively accessible toucts were generated with the IL-4 promoter and en-
hancer primers only when the DNA±protein complexes NFAT1 binding in Th1 cells.
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Figure 5. The Inducible HS Site VA Contains
an Inducible, CsA-Sensitive Transcriptional
Enhancer
(A) SV40 minimal promoter: D10 cells were
transfected with an SV40 promoter-luciferase
plasmid (pGL3) or the same plasmid con-
taining either the 438 bp EcoRI±SwaI frag-
ment (pGL3-VA 438) or the 300 bp PstI±SwaI
fragment (pGL3-VA 300). Twenty-four hours
after transfection, cells were left unstimulated
or stimulated for 8 hr with PMA and ionomycin
(P 1 I) or PMA, ionomycin, and CsA (P 1 I 1
CsA). Results are represented as fold activa-
tion relative to the luciferase activity of pGL3
in unstimulated cells (set at 1; range 30,000±
100,000 relative luciferase units). Bars indicate standard deviations of three independent experiments, which in several cases are too small
to be visible.
(B) IL-4 promoter: D10 cells were transfected with an IL-4 promoter-luciferase construct (pIL4-Luc) or the same construct containing the 438
bp EcoRI±SwaI fragment containing HS site VA (pIL4-Luc VA). Twenty-four hours after transfection, cells were left unstimulated or stimulated
for 8 hr with PMA and ionomycin (P 1 I) or PMA, ionomycin, and CsA (P 1 I 1 CsA). Results are represented as fold activation relative to the
luciferase activity of pIL-4-Luc in unstimulated cells (set at 1; range 150,000±200,000 relative luciferase units). Bars indicate standard deviations
of three independent experiments, which in several cases are too small to be visible.
The Th2-Restricted Transcription Factor GATA3 regions are implicated. Second, the inducible, CsA-sen-
sitive appearance of site VA in primary Th2 cells mirrorsBinds to the IL-4 Enhancer In Vivo
the features of endogenous IL-4 transcription, as wellThe core IL-4 enhancer also contained several putative
as the properties of the site VA enhancer in transientbinding sites for the Th2-restricted transcription factor
transfection assays. Third, the site VA enhancer is theGATA3, identified by visual inspection as related to the
only inducible HS site in the immediate vicinity of theconsensus sequence A/TGATAA/G (Ko and Engel, 1993)
IL-4 gene. The locus is bounded at its 59 and 39 ends by(Figure 4B). To determine whether GATA3 indeed bound
the IL-13 gene and the CNS-specific gene KIF3 (Frazer etto the IL-4 enhancer region in vivo, we again used ChIP
al., 1997). The DNase I HS pattern across this 31 kbassays. The results showed that GATA3 binds in vivo
interval has been mapped, and HS site VA is the onlyto the IL-4 enhancer region in D10 Th2 cells but not in
HS site that is completely restricted to activated Th2D5 Th1 cells that do not express GATA3 (Figure 7A,
cells (Takemoto et al., 1998; this report; S. A., unpub-compare lanes 3 and 4). GATA3 was not observed to
lished data).bind to the IL-4 promoter in Th2 cells (Figure 7B, lane
Our results are consistent with a large body of other4), despite the presence of several reasonably good
evidence, suggesting that the Th2-specific transcriptionGATA binding sites (Ranganath et al., 1998; Zhang et al.,
factor Maf is involved in regulating the inducible phase1998). In control experiments, the IL-4 promoter region
of IL-4 gene transcription rather than in broadly imple-could be detected with the same primers after immuno-
menting a Th2 genetic program (Ho et al., 1996, 1998;
precipitation with anti-NFAT1 (Figure 7C, lane 4). Pre-
Kim et al., 1999). Maf-deficient T cells show a relative
sumably, GATA3 binds with higher affinity to the putative defect in IL-4 but not IL-5 or IL-13 production (Kim et al.,
sites in the IL-4 enhancer, relative to the sites present 1999); conversely, Th2 cells from Maf-transgenic mice
in the IL-4 promoter (Ko and Engel, 1993). However, show a tendency to overexpress IL-4 but not the other
because of the intrinsic limitations of the ChIP technique Th2 cytokines (Ho et al., 1998). Most importantly, Maf
(the immunoprecipitated chromatin contains DNA frag- overexpression in transgenic mice does not result in
ments of average size z1 kb), we cannot definitively IL-4 production by differentiated Th1 cells, indicating
identify the specific GATA sites to which GATA3 is that Maf does not force a Th2 program when ectopically
bound, although they are clearly located in the vicinity expressed (Ho et al., 1998). In complete accordance
of the IL-4 enhancer region and are likely to include with these findings, we have shown that Maf-deficient
those identified as residing within the core IL-4 enhancer T cells are as competent as wild-type T cells in acquiring
in Figure 4C. the differentiated Th2 pattern of DNase I hypersensitivity
during the first stimulation of primary T cells with anti-
gen. Thus, despite the fact that Maf is a direct or indirect
Discussion target of STAT6 and GATA3 (Kurata et al., 1999; Ouyang
et al., 2000), it is unlikely to play a major role in regulating
In this work, we have defined an inducible DNase I HS the acquisition of transcriptional competence on the
site, site VA, located 39 of the IL-4 gene. Several argu- IL-4 locus during Th2 differentiation. Differentiated Maf-
ments support the hypothesis that site VA functions as deficient Th2 cells also showed no impairment, relative
a distal IL-4 enhancer in vivo, cooperating with the IL-4 to wild-type Th2 cells, in the appearance of the inducible
promoter to enable optimal, antigen-dependent and DNase I HS site VA upon stimulation. This result indicates
Th2-restricted expression of IL-4. First, the IL-4 pro- that Maf does not play a critical role in the function of
moter is clearly insufficient to support high-level and the IL-4 enhancer. Rather, the effect of Maf may be
fully Th2-specific transcription of a linked reporter gene localized to its known binding site in the proximal pro-
moter (Ho et al., 1996; Cron et al., 1999).in vivo (Wenner et al., 1997), and thus distal regulatory
Binding of NFAT to a Novel IL-4 Enhancer In Vivo
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Figure 7. GATA3 Binds In Vivo to the IL-4 Enhancer but Not the
Promoter
In vivo binding of GATA3 to the IL-4 promoter and the IL-4 enhancer
in stimulated D5 (Th1) and D10 (Th2) cells was assessed by ChIP.
(A) DNA±protein complexes were immunoprecipitated without anti-
bodies (ªNo Abº) or with anti-GATA3 antibodies. The PCR primers
were specific for the IL-4 enhancer (239 bp).
(B) The same DNA purified in (A) was amplified using primers specific
for the IL-4 promoter.
(C) As a control, the IL-4 promoter region could be detected with
the same primers as in (B) after immunoprecipitation of DNA±protein
complexes with anti-NFAT1 antibodies.
lines and in mice results in impaired Th2 cytokine pro-
duction (Zheng and Flavell, 1997; Ranganath et al., 1998;
Figure 6. Specific In Vivo Binding of NFAT to the IL-4 Promoter and Zhang et al., 1998, 1999; Ouyang et al., 2000). While it
Enhancer in Th2 Cells, and the IFN-g Promoter in Th1 Cells is clear that GATA3 acts directly on the IL-5 promoter
(A) In vivo binding of NFAT1 to the IL-4 promoter and the IL-4 (Zhang et al., 1997; Lee et al., 1998), the mechanism
enhancer in stimulated D5 (Th1) and D10 (Th2) cells was assessed
through which it promotes IL-4 gene expression hasby chromatin immunoprecipitation (ChIP). DNA±protein complexes
been controversial (Zheng and Flavell, 1997; Ranganathwere immunoprecipitated without antibodies (ªNo Abº) or with a
et al., 1998; Zhang et al., 1998, 1999). Our results show-cocktail of antibodies specific for NFAT1. PCR primers specific for
the IL-4 enhancer (ªsite VAº) and the IL-4 promoter amplify products ing that GATA3 binds to the site VA enhancer provide a
of 239 bp and 182 bp, respectively. site of action for this key transcription factor in regulating
(B) The same DNA purified in (A) was amplified using primers specific IL-4 expression. In addition, GATA3 may act through
for the IFN-g promoter, which amplify a product of 250 bp.
other GATA binding elements dispersed throughout the(C) As a control for parts (A) and (B), to show that DNA±protein
IL-4/IL-13 locus, which have been shown to possesscomplexes from D5 Th1 and D10 Th2 cells contained equivalent
enhancer function in transient reporter assays (Ranga-levels of IL-4 promoter/enhancer target sequences, PCR was per-
formed directly on dilutions of DNA from complexes not subjected nath et al., 1998).
to immunoprecipitation. We have shown that the distal site VA enhancer con-
(D) ChIP analysis of CD4 T cells differentiated under Th1 or Th2 tains binding sites for the antigen-induced transcription
conditions for 1 week and either left unstimulated (2) or stimulated
factor NFAT and binds the family member NFAT1 in vivo.(1) for 6 hr with PMA plus ionomycin. DNA was amplified with
The ChIP assay only detects binding and cannot by itselfprimers corresponding to the IL-4 enhancer.
establish whether a given protein acts as a transcrip-(E) As a control for part (D), to show that DNA±protein complexes
from stimulated Th1 and unstimulated or stimulated Th2 cells con- tional activator or repressor when bound to a specific
tained equivalent levels of IL-4 enhancer target sequences, PCR genomic region in vivo. Nevertheless, careful analysis
was performed directly on dilutions of DNA from complexes not of the phenotype of NFAT1-deficient mice (Kiani et al.,
subjected to immunoprecipitation.
1997) suggests that NFAT1 activates transcription when
bound to the IL-4 promoter and enhancer sites. T cells
from NFAT1-deficient mice show a mild degree of Th2
In contrast to Maf, GATA3 appears to play a major skewing and hyperproduce Th2 cytokines (Hodge et al.,
role in specifying the Th2 phenotype (Zheng and Flavell, 1996b; Xanthoudakis et al., 1996), a phenotype that is
1997; Zhang et al., 1999; Ouyang et al., 2000). GATA3 greatly exaggerated in mice lacking both NFAT1 and
is essential for T cell development (Hattori et al., 1996; NFAT4 (Ranger et al., 1998a); in contrast, T cells lacking
Ting et al., 1996); thus, analyses of GATA3-deficient T NFAT2 show a relative impairment of IL-4 production
cells await the development of a conditional GATA3 (Ranger et al., 1998b; Yoshida et al., 1998). These obser-
knockout mouse. Ectopic overexpression of GATA3 in vations have led to the hypothesis that NFAT2 is a posi-
cell lines and in mice results in increased expression of tive regulator of IL-4 gene expression, while NFAT1 and
a spectrum of Th2 cytokines; conversely, overexpres- NFAT4 act solely as negative regulators. This interpreta-
tion cannot be strictly accurate: NFAT1-deficient T cellssion of antisense and dominant-negative GATA3 in cell
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show no difference in peak levels of IL-4 transcripts A prediction from our data is that distal enhancer
relative to wild-type T cells but rather a prolongation of elements may be involved in regulating the expression of
the late phase of IL-4 transcription (Kiani et al., 1997). many if not all NFAT-dependent genes. This is especially
If NFAT1 acted solely as a transcriptional repressor, a likely in the case of the IFN-g gene and other genes
5- to 10-fold increase in peak levels would be expected, that might possess similarly weak and poorly cell-type-
since NFAT1 accounts for 80%±90% of total NFAT and restricted proximal promoter regions (Penix et al., 1993,
is present in wild-type cells at 5- to 10-fold higher levels 1996; Campbell et al., 1996; Young, 1996; Aune et al.,
than in NFAT2 (Xanthoudakis et al., 1996). Thus, it is 1997; Sweetser et al., 1998). The array of NFAT sites in
likely that NFAT1, NFAT2, and NFAT4 all activate the the IL-4 enhancer is reminiscent of the multiple NFAT
early phase of IL-4 gene transcription, but only NFAT1 sites present in the IL-4 and IL-2 promoters and the IL-3
and NFAT4 are able to induce negative feedback mecha- and GM-CSF enhancers (reviewed in Rao et al., 1997).
nisms that blunt the late phase of IL-4 gene transcription The apparent redundancy of NFAT binding to these cy-
(Kiani et al., 1997; Miaw et al., 2000) (reviewed in Agarwal tokine promoter and enhancer regions resembles the
et al., 1999; Kiani et al., 2000). situation at the b-globin locus, where related transcrip-
The most surprising aspect of our studies was that tional activators bind at different stages of erythroid
NFAT1 binding to cytokine regulatory regions was highly development to recurring sequence motifs in the locus
subset-specific in vivo. NFAT proteins are known to be control region and in the globin gene promoters (Orkin,
expressed at equivalent levels in Th1 and Th2 cells and 1995). The use of widely dispersed regulatory regions,
to bind equivalently in vitro to naked DNA containing containing redundant binding sites for the same family
the IL-4 enhancer and the IL-4 promoter (Rooney et al., of transcription factors, may be a general strategy to
1994; Li-Weber et al., 1997; Rincon and Flavell, 1997b; limit the inappropriate expression of cell-type-specific
O. A., unpublished data). Nevertheless, NFAT1 bound genes.
to the IL-4 promoter/enhancer regions in vivo only in
Th2 cells and to the IFN-g promoter region only in differ-
Experimental Proceduresentiated Th1 cells. These results predict that mecha-
nisms operating in the chromatin context restrict the
Miceaccess of NFAT to cytokine regulatory regions in vivo. C57BL/6J and CAF1/J mice (Jackson Laboratories, Bar Harbor,
One hypothesis is that although NFAT1 can bind inde- Maine) were maintained in pathogen-free conditions in barrier facili-
pendently to the regulatory regions in vitro, it is only ties at the Center for Animal Resources and Comparative Medicine,
Harvard Medical School. c-Maf±/± mice (Kim et al., 1999) were kindlycapable of binding them in the context of chromatin if
provided by L. H. Glimcher (Harvard School of Public Health).subset-specific transcription factors such as GATA3 are
also present in the nucleus. Another, not mutually exclu-
sive, hypothesis is that the chromatin structure of the
DNase I Hypersensitivity Analysis
IL-4 enhancer and promoter is selectively altered during The murine T cell clones D5 (Ar-5; Rao et al., 1984) and D10
Th2 differentiation so that these regions become acces- (D10.G4.1; Kaye et al., 1983) were maintained as previously de-
sible to NFAT1 only in differentiated (and stimulated) scribed (Agarwal and Rao, 1998). CD4 T cells were purified from
C57BL/6J mice and differentiated in the Th1 or Th2 direction asTh2 cells. For instance, transcription factors such as
previously described (Agarwal and Rao, 1998). Isolation and DNaseSTAT6 and NFAT, which are acutely induced during the
I digestion of nuclei and purification of genomic DNA were per-first antigen plus cytokine stimulation of naive T cells,
formed as previously described (Agarwal and Rao, 1998; Cockerill,might bind transiently to regulatory regions of the IL-4
2000) using primary Th2 cells differentiated for 2 weeks, which were
gene; this binding might then promote stable alterations either left unstimulated or stimulated for 6 hr with immobilized anti-
in chromatin structure, histone acetylation, or DNA CD3e or with 20 nM PMA plus 2 mM ionomycin in the presence or
methylation status of the adjacent regions that persist absence of 2 mM CsA.
Probe locations are depicted in locus diagrams. The probe fromin the differentiated Th2 cells after the initial stimulus
the 59 end of a 19 kb BamHI fragment spanning the IL-4 locushas died away. In this context, it is noteworthy that both
has been described (Agarwal and Rao, 1998). A similar probe wasthe IL-4 promoter (Lederer et al., 1996) and the site VA
generated from the 39 end of the same fragment (Figures 1±3; loca-enhancer (Figure 4B) contain binding sites for STAT and tion indicated in Figure 1C). For fine mapping of HS site VA, a probe
NFAT. The functions of NFAT and STAT6 would diverge from the 59 end of a 5.5 kb HindIII fragment spanning HS sites V
in the secondary stimulation of differentiated T cells, and VA was used. The IL-4 probes (59 BamHI 19 kb, 39 BamHI 19
since acute transcription of the IL-4 gene requires anti- kb, and 59 HS V/VA) were created by digestion of plasmids containing
these probes and gel purification of the fragments. The exon 4 probegen stimulation and NFAT but is known not to be as
from the IFN-g gene (Agarwal and Rao, 1998) was generated bydependent on IL-4 stimulation and STAT6 (Huang et al.,
PCR and gel purified. The template for PCR was a murine IFN-g1997). A precedent for such a model is provided by
genomic clone (kindly provided by H. A. Young).
studies of the HO endonuclease gene in yeast (Cosma
et al., 1999). In this system, transient binding of the SWI5
transcription factor results in recruitment of the SWI/ Restriction Enzyme Accessibility
SNF chromatin remodeling complex and the SAGA his- Accessibility of the IL-4 locus to the restriction enzyme SwaI was
assessed as described (Boyes and Felsenfeld, 1996). Briefly, SwaItone acetyltransferase complex to the HO gene; these
(150 U) was incubated for 1 hr at room temperature with intact nucleienzyme complexes induce chromatin structural changes
from unstimulated and stimulated T cells (20 nM PMA plus 2 mMthat promote the stable binding of a cell-type-specific
ionomycin for 6 hr). DNA was purified and digested to completion
transcription factor, SBF. We are currently investigating with HindIII. The probe is the same as that used for the fine mapping
whether analogous mechanisms are involved in chroma- of site VA (59 end of a 5.5 kb HindIII fragment encompassing both
tin remodeling and acquisition of transcriptional compe- sites V and VA). Relative hybridization intensities were assessed
using the program NIH Image 1.61.tence by the IL-4 genetic locus.
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Transient Transfection Assays Campbell, P., Pimm, J., Ramassar, V., and Halloran, P. (1996). Identi-
fication of a calcium-inducible, cyclosporine sensitive element inA single copy of the 438 bp EcoRI±SwaI fragment or the 300 bp
PstI±SwaI fragment spanning HS site VA was cloned 59 of the minimal the IFN-gamma promoter that is a potential NFAT binding site.
Transplantation 61, 933±939.SV40 promoter in the luciferase reporter plasmid pGL3 (Promega).
D10 cells were electroporated (960 mF/270 V) and rested overnight. Cockerill, P.N. (2000). Identification of DNase I hypersensitive sites
Transfected cells were divided and either left unstimulated or stimu- within nuclei. Methods Mol. Biol. 130, 29±46.
lated for 8 hr with PMA (20 nM) and ionomycin (2 mM) or PMA, Cosma, M., Tanaka, T., and Nasmyth, K. (1999). Ordered recruitment
ionomycin, and CsA (2 mM). CsA was added 20 min before the of transcription and chromatin remodeling factors to a cell cycle-
stimuli. Cell lysates were harvested and luciferase activity was as- and developmentally regulated promoter. Cell 97, 299±311.
sessed using an automated luminometer (Berthold).
Crabtree, G. (1999). Generic signals and specific outcomes: signal-
ing through Ca21, calcineurin, and NF-AT. Cell 96, 611±614.
Chromatin Immunoprecipitation (ChIP) Assays
Cron, R., Bort, S., Wang, Y., Brunvand, M., and Lewis, D. (1999). TChIP analysis was carried out essentially as described (Parekh and
cell priming enhances IL-4 gene expression by increasing nuclearManiatis, 1999). Unstimulated or stimulated (6 hr, 20 nM PMA plus
factor of activated T cells. J. Immunol. 162, 860±870.2 mM ionomycin) D5 Th1 cells and D10 Th2 cells (5 to 15 3 107) or
Frazer, K.A., Ueda, Y., Zhu, Y., Gifford, V.R., Garofalo, M.R., Mohan-CD4 T cells differentiated under Th1 or Th2 conditions for 1 week
das, N., Martin, C.H., Palazzolo, M.J., Cheng, J., and Rubin, E.M.(Agarwal and Rao, 1998) were cross-linked using formaldehyde.
(1997). Computational and biological analysis of 680 kb of DNANuclei were isolated and sonicated, and DNA±protein complexes
sequence from the human 5q31 cytokine gene cluster region. Ge-were purified by CsCl gradient centrifugation. The chromatin was
nome Res. 7, 495±512.immunoprecipitated using a cocktail (5 mg) of anti-67.1 and anti-
NFAT1-C antibodies specific for the family member NFAT1 (Wang Hattori, N., Kawamoto, H., Fujimoto, S., Kuno, K., and Katsura, Y.
et al., 1995) or with 5 mg of anti-GATA3 antibodies (Santa Cruz). (1996). Involvement of transcription factors TCF-1 and GATA-3 in
Following deproteination and reversal of cross-links, the presence the initiation of the earliest step of T cell development in the thymus.
of selected DNA sequences was assessed by PCR. The primers J. Exp. Med. 184, 1137±1147.
used were as follows: site VA, 59-AGGGCACTTAAACATTGC-39 and Henkel, G., Weiss, D.L., McCoy, R., Deloughery, T., Tara, D., and
59-ACGCCTAAGCACAATTCC-39 (239 bp product); IL-4 promoter, Brown, M.A. (1992). A DNase I-hypersensitive site in the second
59-TTGGTCTGATTTCACAGG-39 and either 59-AACAATGCAATGCT intron of the murine IL-4 gene defines a mast cell-specific enhancer.
GGC-39 (182 bp product) or 59-ATCAATAGCTCTGTGCCG-39 (240 J. Immunol. 149, 3239±3246.
bp product); IFN-g promoter, 59-GCTCTGTGGATGAGAAAT-39 and
Ho, I.-C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). The59-AAGATGGTGACAGATAGG-39 (250 bp product).
proto-oncogene c-maf is responsible for tissue-specific expression
of interleukin-4. Cell 85, 973±983.
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